WEREWOLF THERAPEUTICS INC (HOWL)
US95075A1079 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 139.19M | 134.34M | 129.30M | 157.50M | 92.60M | |||
| Receivables | 775.00K | 1.35M | 6.90M | N/A | N/A | |||
| Other Current Assets | 2.32M | 2.68M | 4.00M | 3.50M | 300.00K | |||
| Total Current Assets | 142.28M | 138.37M | 140.20M | 161.10M | 92.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.04M | 14.85M | 17.50M | 16.30M | 3.10M | |||
| Other Non-Current Assets | 21.27M | 21.62M | 2.60M | 1.90M | 400.00K | |||
| Total Non-Current Assets | 35.32M | 36.46M | 20.00M | 18.20M | 3.50M | |||
| TOTAL ASSETS | 177.60M | 174.83M | 160.20M | 179.30M | 96.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.67M | 6.67M | N/A | N/A | 680.00K | |||
| Accrued Expenses | 7.45M | 10.47M | 16.20M | 9.80M | 4.30M | |||
| Accounts Payable | 1.59M | 1.34M | 1.20M | 2.00M | 1.00M | |||
| Other Current Liabilities | 502.00K | 907.00K | 6.50M | N/A | N/A | |||
| Total Current Liabilities | 21.21M | 19.38M | 24.00M | 11.90M | 5.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 27.75M | 32.66M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.05M | 11.43M | 13.90M | 14.60M | 1.90M | |||
| Total Non-Current Liabilities | 38.80M | 44.08M | 13.90M | 14.60M | 1.90M | |||
| TOTAL LIABILITIES | 60.01M | 63.46M | 37.90M | 26.50M | 7.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -360.27M | -344.07M | -306.70M | -252.90M | -51.90M | |||
| Additional Paid In Capital | 477.85M | 455.44M | 429.00M | 405.70M | 0.00 | |||
| Common Shares | 4.00K | 4.00K | 0.00 | 0.00 | 141.10M | |||
| Shares Outstanding | 43.28M | 39.11M | 31.40M | 27.30M | 27.50M | |||
| Tangible Book Value per Share | 2.72 | 2.85 | 3.89 | 5.60 | -1.89 | |||
| Total Shareholders' Equity | 117.59M | 111.37M | 122.30M | 152.80M | 89.20M | |||
| TOTAL LIABILITIES AND EQUITY | 177.60M | 174.83M | 160.20M | 179.30M | 96.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.24 | 0.29 | N/A | N/A | N/A | |||
| Current Ratio | 6.71 | 7.14 | 5.84 | 13.54 | 17.53 | |||
| Return On Assets (ROA) | -23.42% | -21.37% | -33.59% | -112.62% | -29.27% | |||
| Return On Equity (ROE) | -35.37% | -33.55% | -44.00% | -132.15% | -31.64% | |||
All data in USD